Eric van Gorp

Dolutegravir as maintenance monotherapy for HIV (DOMONO): a phase 2, randomised non-inferiority trial.

Eleni-Rosalina Andrinopoulou, Bart Rijnders, E. Andrinopoulou, 2017, The lancet. HIV.